Therapeutic keratoplasty for microbial keratitis

Current Opinion in Ophthalmology

Volumn 21, Issue 4, 2010, Pages 293-300

  Sharma, Namrata ^a   Sachdev, Ritika ^a   Jhanji, Vishal ^a,b   Titiyal, Jeewan S ^a   Vajpayee, Rasik B ^a,b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Nonhealing corneal ulcer; Perforated corneal ulcer; Therapeutic keratoplasty

Indexed keywords

ACICLOVIR; ANTIGLAUCOMA AGENT; CORTICOSTEROID; MANNITOL; VALACICLOVIR;

ACANTHAMOEBA KERATITIS; ANESTHESIA COMPLICATION; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; ASPERGILLUS; BACTERIAL KERATITIS; CATARACT; CONVALESCENCE; CORNEA PRESERVATION; DEEP ANTERIOR LAMELLAR KERATOPLASTY; DESCEMET MEMBRANE; DONOR SELECTION; EYE INFECTION; FUSARIUM SOLANI; GENERAL ANESTHESIA; GLAUCOMA; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HERPES SIMPLEX; HERPES SIMPLEX KERATITIS; HISTOPATHOLOGY; HUMAN; INFECTION PREVENTION; KERATOMYCOSIS; LOCAL ANESTHESIA; PAECILOMYCES LILACINUS; PENETRATING KERATOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; RISK REDUCTION; TREATMENT INDICATION; TREATMENT OUTCOME;

CORNEAL TRANSPLANTATION; CORNEAL ULCER; EYE INFECTIONS; HUMANS; KERATOPLASTY, PENETRATING;

EID: 77954028247     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32833a8e23     Document Type: Review

References (51)

1. Fine M. Therapeutic keratoplasty. Trans Acad Ophthalmol Otolaryngol 1960; 64:786-808.
2. Tan DT, Janardhanan P, Zhou H, et al. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. Ophthalmology 2008; 115:975-982.
3. Flores VG, Dias HL, de Castro RS. Penetrating keratoplasty indications in 'Hospital das Clínicas-UNICAMP'. (Portuguese) Arq Bras Oftalmol 2007; 70:505-508.
4. Shi W, Wang T, Xie L, et al. Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology 2010; 117:890-896.
5. Bhartiya P, Daniell M, Constantinou M, et al. Fungal keratitis in Melbourne. Clin Exp Ophthalmol 2007; 35:124-130.
6. Limaiem R, Mnasri H, Merdassi A, et al. Therapeutic penetrating keratoplasty in herpes infected eye. (French) Bull Soc Belge Ophtalmol 2009; 311:37-41.
7. Kitzmann AS, Goins KM, Sutpin JE, et al. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 2009; 116:864-869.
8. Anshu A, Parthasarathy A, Mehta JS, et al. Outcomes of therapeutic deep lamellar keratoplasty and penetrating keratoplasty for advanced infectious keratitis: a comparative study. Ophthalmology 2009; 116:615-623.
9. Ti SE, Scott JA, Janardhanan P, Tan DT. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol 2007; 143:755-762.
10. Saeed A, D'Arcy F, Stack J, et al. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea 2009; 28:285-292.
11. Jhanji V, Constantinou M, Taylor HR, et al. Microbiological and clinical profiles of patients with microbial keratitis residing in nursing homes. Br J Ophthalmol 2009; 93:1639-1642.
12. Jhanji V, Moorthy S, Vajpayee RB. Microbial keratitis in patients with Down's syndrome: a retrospective study. Cornea 2009; 28:163-165.
13. Al-Shehri A, Jastaneiah S, Wagoner MD. Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital. Int Ophthalmol 2009; 29:143-152.
14. Kawashima M, Kawakita T, Den S. Surgical management of corneal perforation secondary to gonococcal keratoconjunctivitis. Eye (Lond.) 2009; 23:339-344.
15. Susiyanti M, Mehta JS, Tan DT. Bilateral deep anterior lamellar keratoplasty for the management of bilateral post-LASIK mycobacterial keratitis. J Cataract Refract Surg 2007; 33:1641-1643.
16. Ibrahim MM, Vanini R, Ibrahim FM, et al. Epidemiologic aspects and clinical outcome of fungal keratitis in southeastern Brazil. Eur J Ophthalmol 2009; 19:355-361.
17. Pérez-Balbuena AL, Vanzzini-Rosano V, Valadéz-Virgen Jde J, et al. Fusarium keratitis in Mexico. Cornea 2009; 28:626-630.
18. Thew MR, Todd B. Fungal keratitis in far north Queensland, Australia. Clin Exp Ophthalmol 2008; 36:721-724.
19. Yuan X, Wilhelmus KR, Matoba AY, et al. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol 2009; 147:691-696.
20. Manikandan P, Varga J, KocsubéS, et al. Mycotic keratitis due to Aspergillus nomius. J Clin Microbiol 2009; 47:3382-3385.
21. Badenoch PR, Mills RA, Chang JH, et al. Pythium insidiosum keratitis in an Australian child. Clin Exp Ophthalmol 2009; 37:806-809.
22. Mandell KJ, Colby KA. Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species. Cornea 2009; 28:1167-1169.
23. Por YM, Mehta JS, Chua JL, et al. Acanthamoeba keratitis associated with contact lens wear in Singapore. Am J Ophthalmol 2009; 148:7-12.
24. Pineda R 2nd, Kocatürk T, Bhui RD. Visual outcome and rehabilitation in a case of bilateral Acanthamoeba sclerokeratitis. Cornea 2007; 26:1150-1152.
25. Vassileva PI, Hergeldzhieva TG. Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol 2009; 247:1701-1706.
26. Koenig Y, Bock F, Horn F, et al. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009; 247:1375-1382.
27. Gerten G. Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery. Cornea 2008; 27:1195-1199.
28. Mackenzie SE, Tucker WR, Poole TR. Bevacizumab (avastin) for corneal neovascularization: corneal light shield soaked application. Cornea 2009; 28:246-247.
29. Riddle Jr. HK, Price MO, Price FW Jr. Topical anesthesia for penetrating keratoplasty. Cornea 2004; 23:712-714.
30. Rao GN, Garg P, Sridhar MS. Therapeutic penetrating keratoplasty. In: Brightbill FS, editor. Corneal surgery: theory, technique and tissue, 4th ed St. Louis: Mosby; 2009. pp. 439-444.
31. Yao YF, Zhang YM, Zhou P, et al. Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas. Br J Ophthalmol 2003; 87:543-547.
32. Wang R, Zou L, Dong D. Evaluation of the results of therapeutic lamellar keratoplasty and penetrating keratoplasty for fungal corneal ulcer. (Chinese) Zhonghua Yan Ke Za Zhi 2000; 36:18-20.
33. Sony P, Sharma N, Vajpayee RB, Ray M. Therapeutic keratoplasty for infectious keratitis: a review of the literature. CLAO J 2002; 28:111-118.
34. Vajpayee RB, Singhvi A, Sharma N, et al. Penetrating keratoplasty for perforated corneal ulcers: preservation of iris by corneal debulking. Cornea 2006; 25:44-46.
35. Banitt M, Berenbom A, Shah M, et al. A case of polymicrobial keratitis violating an intact lens capsule. Cornea 2008; 27:1057-1061.
36. Shimmura Shigeto, Tsubota Kazuo. Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol 2006; 17:349-355.
37. Xie L, Hu J, Shi W. Treatment failure after lamellar keratoplasty for fungal keratitis. Ophthalmology 2008; 115:33-36.
38. Sarnicola V, Toro P. Deep anterior lamellar keratoplasty in herpes simplex corneal opacities. Cornea 2010; 29:60-64.
39. Shimmura S, Shimazaki J, Tsubota K. Therapeutic deep lamellar keratoplasty for cornea perforation. Am J Ophthalmol 2003; 135:896-897.
40. Tong L, Tan DT, Abano JM, et al. Deep anterior lamellar keratoplasty in a patient with descemetocele following gonococcal keratitis. Am J Ophthalmol 2004; 138:506-507.
41. Por YM, Tan YL, Mehta JS, et al. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations. Cornea 2009; 28:451-455.
42. Sonmez B, Beden U, Erkan D. Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer. Int Ophthalmol 2009; 29:123-125.
43. van Rooij J, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 2003; 110:1916-1919.
44. Garcia DD, Farjo Q, Musch DC, et al. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 2007; 26:930-934.
45. Jansen AF, Rijneveld WJ, Remeijer L, et al. Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. Cornea 2009; 28:843-845.
46. Goldblum D, Bachmann C, Tappeiner C, et al. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis. Br J Ophthalmol 2008; 92:1201-1205.
47. Shi W, Liu M, Gao H, et al. Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment. Graefes Arch Clin Exp Ophthalmol 2009; 247:1383-1388.
48. Kashiwabuchi RT, de Freitas D, Alvarenga LS, et al. Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. Acta Ophthalmol 2008 [Epub ahead of print].
49. de Oliveira FC, Dantas PE, de Marco ES, et al. Long-term follow-up of a case series of therapeutic corneal transplant. (Portuguese) Arq Bras Oftalmol 2007; 70:625-631.
50. Xie L, Zhai H, Shi W. Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea 2007; 26:158-162.
51. Chen WL, Wu CY, Hu FR, et al. Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 1987 to 2001. Am J Ophthalmol 2004; 137:736-743.